Pathological complete response (pCR) rates after carboplatin-containing neoadjuvant chemotherapy in patients with germline BRCA (gBRCA) mutation and triple-negative breast cancer (TNBC): Results from GeparSixto - von Minckwitz, G; Hahnen, E; Fasching, P A (J Clin Oncol, 2014)
(Suppl.)